Showing 1-10 of about 108 articles.
PositiveID Corporation
Photo Release -- PositiveID Corporation Launches Development of Firefly Dx to Confirm Biological Threats in the Field Within Minutes
DELRAY BEACH, Fla., April 29, 2013 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSIDD), a developer of biological detection and diagnostics solutions, today announced it has launched the development of the Firefly Dx detection system ("Firefly"), a portable, hand-held, point-of-need molecular diagnostic system, which is being designed to provide test results from sample input through reporting of results in less than 15 to 30 minutes depending on the type of test performed. Firefly is expected to quickly process human and agricultural samples to provide accurate confirmation of biological threats via a smart-phone application.
PositiveID Corporation
PositiveID Corporation Announces Reverse Stock Split
DELRAY BEACH, Fla., April 22, 2013 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of biological detection and diagnostics solutions, today announced its Board of Directors has approved a reverse split of its common stock at a ratio of 1-for-25 commencing at the open of trading on April 23, 2013. The Company's ticker symbol will be PSIDD for approximately 20 trading days after the split to designate that it is trading on a post-reverse split basis. As a result of the reverse stock split, the number of outstanding common shares will be reduced to approximately 15 million shares. No fractional shares will be issued as a result of the reverse stock split, and stockholders who otherwise would be entitled to a fractional share will receive, in lieu thereof, a cash payment based on the volume weighted average price of the Company's common stock as reported on April 22, 2013 on the Over the Counter Bulletin Board Market. The Company's transfer agent will provide instructions to stockholders regarding the process for exchanging shares.
PositiveID Corporation
PositiveID Corporation Reviews 2012 Highlights and 2013 Outlook
DELRAY BEACH, Fla., March 12, 2013 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or the "Company") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today issued an update on the progress of its strategic plan to refocus the Company on its patented and patent pending technologies to serve the estimated $3.1 Billion BioWatch Generation 3 program, which is designed to protect the American public from a biological attack. This update is intended to present stockholders with a review of major accomplishments for 2012 and an outlook for 2013.
PositiveID Corporation
PositiveID Corporation Announces License of iglucose Technology for Up to $2 Million
DELRAY BEACH, Fla., Feb. 20, 2013 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today announced it has entered into an agreement to license its iglucose™ technology to Smart Glucose Meter Corp. ("SGMC") for up to $2 million based on potential future revenues of glucose test strips sold by SGMC. These revenues will range between $0.0025 and $0.005 per strip. A person with diabetes who tests three times per day will use over 1,000 strips per year.
PositiveID Corporation
PositiveID Reports Issuance of Draft RFP From Dept of Homeland Security for BioWatch Generation 3
DELRAY BEACH, Fla., Feb. 6, 2013 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of biological detection and diagnostics solutions, today announced that the U.S. Department of Homeland Security ("DHS") released a draft request for proposal ("RFP") for Stage 1 of BioWatch Generation 3, an autonomous biodetection system designed to protect the nation against biological threats. The final RFP for Stage 1 is expected to be released in the government's third quarter of fiscal 2013, which ends June 30th. The Stage 1 contract is expected to have a performance period of 18 months. The full roll-out of BioWatch Generation 3 is estimated at $3.1 billion over the next five years.
PositiveID Corporation
PositiveID Corporation Retains Secure Strategy Group
DELRAY BEACH, Fla. and NEW YORK, Jan. 8, 2013 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (OTCBB:PSID), an emerging growth company and developer of airborne bio-threat detection systems for America's homeland defense industry as well as advanced technologies for rapid medical testing and diabetes management, today announced it has retained Secure Strategy Group ("SSG") for strategic and financial advisory services.
PositiveID Corporation
PositiveID Corporation Enters Into License Agreement and Teaming Agreement With The Boeing Company
DELRAY BEACH, Fla., Dec. 20, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (OTCBB:PSID), an emerging growth company and developer of airborne bio-threat detection systems for America's homeland defense industry as well as advanced technologies for rapid medical testing and diabetes management, today announced it has entered into a license agreement and a teaming agreement with The Boeing Company ("Boeing"), including a license fee to PositiveID of $2.5 million.
PositiveID Corporation
PositiveID Corporation Announces Teaming Agreement With SAIC to Pursue Defense Threat Reduction Agency Contracts
DELRAY BEACH, Fla., Nov. 6, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (OTCBB:PSID), an emerging growth company and developer of airborne bio-threat detection systems for America's homeland defense industry as well as advanced technologies for diabetes management and rapid medical testing, today announced it has signed a Teaming Agreement ("Teaming Agreement") with Science Applications International Corporation ("SAIC") (NYSE:SAI) to pursue the Defense Threat Reduction Agency ("DTRA") Indefinite Delivery/Indefinite Quantity ("IDIQ") Multiple Award Contracts supporting the Weapons of Mass Destruction ("WMD") - Defeat Technology, Arms Control, and Nuclear Technology Electromagnetic Research and Development/ Survivability and Infrastructure programs.
PositiveID Corporation
PositiveID Corporation Provides Third Quarter 2012 Update
DELRAY BEACH, Fla., Oct. 22, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), an emerging growth company and developer of airborne bio-threat detection systems for America's homeland defense industry as well as advanced technologies for diabetes management and rapid medical testing, today provided a third quarter 2012 business update to its stockholders. The Company continues to focus on the BioWatch Generation 3, Phase II procurement. In September, the Department of Homeland Security ("DHS") announced a revised procurement strategy for BioWatch Generation 3, Phase II, which will consist of a two-stage procurement including two to three years of testing estimated at $89 million. A draft request for proposal ("RFP") for the first stage is scheduled to be released in the fourth quarter of calendar 2012.
Showing 1-10 of about 108 articles.